Community Medicine Seminar Series
"What CABG Teaches Us About Innovation"
George J. Agich, Ph.D.
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Thursday, April 28, 2005 12:00 - 1:30 PM
The Link Room (CG076)
University of Connecticut Health Center
For lunch, please RSVP by April 25, 2005 to Theo Ungewitter at 860.679.5495.
About the Speaker
Dr
Agich is a Professor of Medicine in the Cleveland Clinic Lerner College of
Medicine of Case Western Reserve University and a member and former Chairman
(1997-2004) of the Department of Bioethics with a joint appointment in the
Transplant Center at the Cleveland Clinic Foundation, Cleveland, Ohio. During
the 2003-2004 Winter Term, he was the Freiwillige Akademische Gesellschaft
Visiting Professor at the University of Basel, Switzerland. He earned his
bachelor degree in Philosophy and English from Duquesne University and a masters
and doctorate in Philosophy from the University of Texas at Austin. Dr. Agich
directs the Cleveland Clinic's Ethics Consultation Service that provides over
240 ethics consultations annually as well as weekly Critical Care Ethics Liaison
Rounds in six intensive care units. He has served on the CCF Liver and Heart
Transplantation Selection Committees and is Chairman of the Ohio Solid Organ
Transplantation Consortium Ethics Committee. He has also been active in professional
societies and serves on a number of editorial boards and national grant review
committees, including an NIH study section. Dr. Agich is the author of over
100 peer-reviewed articles and four books on a wide range of topics including
autonomy in long-term care, ethics consultation, philosophical aspects of
psychiatric nosology, and research ethics. Cambridge University Press published
his most recent book, Dependence and Autonomy in Long Term Care in
2003. His current research includes questions of authority and methodology
in ethics consultation as well as the ethics of innovation in medicine and
surgery.
- Dr. Agich is a candidate for the Joseph M. Healey Endowed Chair in the Medical Humanities, Law & Bioethics
About the Educational Activity
Target Audience
Physicians and Other Health Professionals, Medical and Dental Students, Faculty
Objectives
At the end of this presentation, participants will:
- appreciate that the standard model for thinking about innovation in medicine carries value-laden assumptions that complicate the social regulation of innovation;
- understand that the structural and developmental features of innovations associated with CABG involve a unique process of social oversight; and
- understand the importance of a multidisciplinary humanities approach to a complex problem like innovation in medicine.
Accreditation
The Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians accredits The University of Connecticut School of Medicine. The University of Connecticut School of Medicine takes responsibility for the content, quality and scientific integrity of this CME activity.
The University of Connecticut School of Medicine designates this educational activity for a maximum of 1.5 hours per session in category 1 credit towards the AMA Physicians Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
Conflict of Interest
All faculty participating in Continuing Medical Education activities sponsored
by the University of Connecticut School of Medicine are required to disclose
to the program audience any real or apparent conflict of interest related
to the content of
their presentations. Professor Agich does not have a financial interest/arrangement
or affiliation with any organizations that could be perceived as a real or
apparent conflict of interest in the context of the subject of his presentation,
nor will he address any unlabeled use for a drug in this presentation.
Sponsors
University of Connecticut School of Medicine Office of Continuing Education, Department of Community Medicine and supported in part by an unrestricted educational grant from Agouron Pharmaceuticals, Inc.

